Next Article in Journal
Magnetic Resonance Imaging Using a Chimeric Anti-Glypican-3 Antibody Conjugated with Gadolinium Selectively Detects Glypican-3-Positive Hepatocellular Carcinoma In Vitro and In Vivo
Next Article in Special Issue
The Pathogenesis of the Neurofibroma-to-Sarcoma Transition in Neurofibromatosis Type I: From Molecular Profiles to Diagnostic Applications
Previous Article in Journal
Comment on Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers 2025, 17, 1306
Previous Article in Special Issue
The RXR Agonist MSU-42011 Reduces Tumor Burden in a Murine Preclinical NF1-Deficient Model
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 17
Issue 20
10.3390/cancers17203356
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Reply to Cancers 2025, 17(20), 3355.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Reply

Reply to Taal et al. Comment on “Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers 2025, 17, 1306”

by
Maria Pia Iasella
1,†,
Dries Ruttens
2,3,†,
Daphne Hompes
4,
Vincent Vandecaveye
5,
Raf Sciot
6,
Christophe Deroose
7,
Thomas Douchy
4,
Thomas Decramer
8,
Sandra Jacobs
2,
Ellen Denayer
1,
Frank Van Calenbergh
8,
Eric Legius
1 and
Hilde Brems
1,*
1
Centre for Human Genetics, University Hospitals Leuven, KU Leuven, 3000 Leuven, Belgium
2
Department of Paediatric Oncology, University Hospitals Leuven, 3000 Leuven, Belgium
3
Department of Paediatric Oncology, Princess Máxima Centre for Pediatric Oncology, 3584 CS Utrecht, The Netherlands
4
Department of Surgical Oncology, University Hospitals Leuven, 3000 Leuven, Belgium
5
Radiology Department, University Hospitals Leuven, 3000 Leuven, Belgium
6
Department of Pathology, University Hospitals Leuven, KU Leuven, 3000 Leuven, Belgium
7
Nuclear Medicine, University Hospitals Leuven, and Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium
8
Department of Neurosurgery, University Hospitals Leuven, 3000 Leuven, Belgium
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Cancers 2025, 17(20), 3356; https://doi.org/10.3390/cancers17203356
Submission received: 25 June 2025 / Revised: 26 August 2025 / Accepted: 28 September 2025 / Published: 17 October 2025
(This article belongs to the Special Issue Neurofibromatosis)
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

We would like to sincerely thank Dr [...]

Share and Cite

MDPI and ACS Style

Iasella, M.P.; Ruttens, D.; Hompes, D.; Vandecaveye, V.; Sciot, R.; Deroose, C.; Douchy, T.; Decramer, T.; Jacobs, S.; Denayer, E.; et al. Reply to Taal et al. Comment on “Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers 2025, 17, 1306”. Cancers 2025, 17, 3356. https://doi.org/10.3390/cancers17203356

AMA Style

Iasella MP, Ruttens D, Hompes D, Vandecaveye V, Sciot R, Deroose C, Douchy T, Decramer T, Jacobs S, Denayer E, et al. Reply to Taal et al. Comment on “Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers 2025, 17, 1306”. Cancers. 2025; 17(20):3356. https://doi.org/10.3390/cancers17203356

Chicago/Turabian Style

Iasella, Maria Pia, Dries Ruttens, Daphne Hompes, Vincent Vandecaveye, Raf Sciot, Christophe Deroose, Thomas Douchy, Thomas Decramer, Sandra Jacobs, Ellen Denayer, and et al. 2025. "Reply to Taal et al. Comment on “Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers 2025, 17, 1306”" Cancers 17, no. 20: 3356. https://doi.org/10.3390/cancers17203356

APA Style

Iasella, M. P., Ruttens, D., Hompes, D., Vandecaveye, V., Sciot, R., Deroose, C., Douchy, T., Decramer, T., Jacobs, S., Denayer, E., Van Calenbergh, F., Legius, E., & Brems, H. (2025). Reply to Taal et al. Comment on “Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers 2025, 17, 1306”. Cancers, 17(20), 3356. https://doi.org/10.3390/cancers17203356

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop